124 related articles for article (PubMed ID: 3778526)
1. Metabolism of the anthracycline antibiotic daunorubicin to daunorubicinol and deoxydaunorubicinol aglycone in hepatocytes isolated from the rat and the rabbit.
Gewirtz DA; Yanovich S
Biochem Pharmacol; 1986 Nov; 35(22):4059-64. PubMed ID: 3778526
[TBL] [Abstract][Full Text] [Related]
2. Daunorubicin metabolites in human urine.
Takanashi S; Bachur NR
J Pharmacol Exp Ther; 1975 Oct; 195(1):41-9. PubMed ID: 1181403
[TBL] [Abstract][Full Text] [Related]
3. Initial biotransformations of daunorubicin to aglycones by rat liver microsomes.
Schwartz HS; Parker NB
Cancer Res; 1981 Jun; 41(6):2343-8. PubMed ID: 7237433
[TBL] [Abstract][Full Text] [Related]
4. Metabolism of adriamycin in hepatocytes isolated from the rat and the rabbit.
Gewirtz DA; Yanovich S
Biochem Pharmacol; 1987 Jun; 36(11):1793-8. PubMed ID: 3579974
[TBL] [Abstract][Full Text] [Related]
5. Daunorubicin and daunorubicinol pharmacokinetics in plasma and tissues in the rat.
Cusack BJ; Young SP; Olson RD
Cancer Chemother Pharmacol; 1995; 35(3):213-8. PubMed ID: 7805179
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of daunorubicinol in the rabbit: comparison with daunorubicin.
Maniez-Devos DM; Baurain R; Trouet A; Lesne M
J Pharmacol; 1986; 17(1):14-20. PubMed ID: 3713197
[TBL] [Abstract][Full Text] [Related]
7. Role of daunorubicinol in daunorubicin-induced cardiotoxicity as evaluated with the model of isolated perfused rat heart.
Platel D; Bonoron-Adèle S; Robert J
Pharmacol Toxicol; 2001 May; 88(5):250-4. PubMed ID: 11393585
[TBL] [Abstract][Full Text] [Related]
8. Daunorubicin-induced cardiac injury in the rabbit: a role for daunorubicinol?
Cusack BJ; Mushlin PS; Voulelis LD; Li X; Boucek RJ; Olson RD
Toxicol Appl Pharmacol; 1993 Feb; 118(2):177-85. PubMed ID: 8441996
[TBL] [Abstract][Full Text] [Related]
9. Loss of fluorescence by anthracycline antibiotics: effects of xanthine oxidase and identification of the nonfluorescent metabolites.
Dodion P; Bernstein AL; Fox BM; Bachur NR
Cancer Res; 1987 Feb; 47(4):1036-9. PubMed ID: 3467841
[TBL] [Abstract][Full Text] [Related]
10. Daunorubicin-induced DNA lesions in isolated rat hepatocytes and mammary epithelial cells.
Howell SK; Haidle CW; Wang YM
Biochim Biophys Acta; 1986 Dec; 868(4):254-61. PubMed ID: 3790570
[TBL] [Abstract][Full Text] [Related]
11. Distribution and metabolism of rubidazone and daunorubicin in mice.
Baurain R; Deprez-De Campeneere D; Trouet A
Cancer Chemother Pharmacol; 1979; 2(1):37-41. PubMed ID: 498418
[TBL] [Abstract][Full Text] [Related]
12. Comparative metabolism of daunorubicin and 4-demethoxydaunorubicin in mice and rabbits.
Broggini M; Sommacampagna B; Paolini A; Dolfini E; Donelli MG
Cancer Treat Rep; 1986 Jun; 70(6):697-702. PubMed ID: 3524823
[TBL] [Abstract][Full Text] [Related]
13. Doxorubicin and daunorubicin plasmatic, hepatic and renal disposition in the rabbit with or without enterohepatic circulation.
Maniez-Devos DM; Baurain R; Lesne M; Trouet A
J Pharmacol; 1986; 17(1):1-13. PubMed ID: 3713196
[TBL] [Abstract][Full Text] [Related]
14. Different cytotoxicity and metabolism of doxorubicin, daunorubicin, epirubicin, esorubicin and idarubicin in cultured human and rat hepatocytes.
Le Bot MA; Bégué JM; Kernaleguen D; Robert J; Ratanasavanh D; Airiau J; Riché C; Guillouzo A
Biochem Pharmacol; 1988 Oct; 37(20):3877-87. PubMed ID: 3190734
[TBL] [Abstract][Full Text] [Related]
15. Age-related pharmacokinetics of daunorubicin and daunorubicinol following intravenous bolus daunorubicin administration in the rat.
Cusack BJ; Young SP; Vestal RE; Olson RD
Cancer Chemother Pharmacol; 1997; 39(6):505-12. PubMed ID: 9118462
[TBL] [Abstract][Full Text] [Related]
16. Adipocytes Sequester and Metabolize the Chemotherapeutic Daunorubicin.
Sheng X; Parmentier JH; Tucci J; Pei H; Cortez-Toledo O; Dieli-Conwright CM; Oberley MJ; Neely M; Orgel E; Louie SG; Mittelman SD
Mol Cancer Res; 2017 Dec; 15(12):1704-1713. PubMed ID: 29117945
[TBL] [Abstract][Full Text] [Related]
17. o-Methylation on anthracyclines and anthracyclinones. New o-methyl ethers of daunorubicin and its analogues.
Cassinelli G; Di Matteo F; Forenza S; Ripamonti MC; Ruggieri D; Vigevani A; Arcamone F
Farmaco Sci; 1982 Aug; 37(8):501-13. PubMed ID: 6957317
[TBL] [Abstract][Full Text] [Related]
18. Investigations of calsequestrin as a target for anthracyclines: comparison of functional effects of daunorubicin, daunorubicinol, and trifluoperazine.
Charlier HA; Olson RD; Thornock CM; Mercer WK; Olson DR; Broyles TS; Muhlestein DJ; Larson CL; Cusack BJ; Shadle SE
Mol Pharmacol; 2005 May; 67(5):1505-12. PubMed ID: 15705743
[TBL] [Abstract][Full Text] [Related]
19. Aging increases the cardiotoxicity of daunorubicin and daunorubicinol in the rat.
Cusack BJ; Mushlin PS; Johnson CJ; Vestal RE; Olson RD
J Gerontol A Biol Sci Med Sci; 1996 Sep; 51(5):B376-84. PubMed ID: 8808986
[TBL] [Abstract][Full Text] [Related]
20. Modulation of anthracycline accumulation and metabolism in rat hepatocytes in culture by three revertants of multidrug resistance.
Le Bot MA; Kernaleguen D; Robert J; Berlion M; Riché C
Cancer Chemother Pharmacol; 1994; 35(1):53-8. PubMed ID: 7987977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
